| ID | 原文 | 译文 |
| 1272 | 2~7μg/mL | 2~7 μg/mL |
| 1273 | 谷浓度与骨髓抑制不良反应相关，需密切监测血三系水平。 | The trough concentration correlates with myelosuppression adverse reactions. The blood routine test needs to be closely monitored. |
| 1275 | 当日给药前30min内 | 30 min before the drug administration |
| 1276 | 1~5.5μg/mL | 1~5.5 μg/mL |
| 1277 | 谷浓度与疗效和肝功能受损等不良反应相关 | The trough concentration correlates with the therapeutic efficacy and adverse reactions such as impaired liver function. |
| 1278 | 注意潜在的药物相互作用 | Paying attention to the potential drug interactions |
| 1279 | 由于抗病毒药物如洛匹那韦/利托那韦经肝脏CYP3A酶代谢，如有多重用药时须仔细排查可能的药物相互作用，合理选择药物。 | Antiviral drugs such as lopinavir/ritonavir are metabolized through the enzyme CYP3A in the liver. When patients receiving concomitant medications, the potential drug interactions need to be carefully screened. |
| 1280 | 有关抗病毒药物与常见基础疾病用药的相互作用见表2。 | Table 2 shows interactions bet ween antiviral drugs and common drugs for underlying diseases. |
| 1281 | 表2 抗病毒药物与常见基础疾病用药的相互作用 | Table 2 Interactions bet ween antiviral drugs and common drugs for underlying |
| 1282 | 药品名称 | Drug names |